IMMUNITYBIO INC (IBRX)
US45256X1037 - Common Stock
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 930K 52.46% | 240K -74.19% | 622K 159.17% | 16.269M 2,515.59% | 140.92M 766.19% | 275.89M 95.78% | 860.05M 211.74% | 1.807B 110.10% | 4.17B 130.77% | 7.104B 70.36% | 12.27B 72.72% | |
| EBITDA YoY % growth | -316.04M -60.04% | -332.36M -5.16% | -342.852M -3.16% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -330.28M -57.11% | -350.62M -6.16% | -361.364M -3.06% | -374.64M -3.67% | -299.602M 20.03% | -191.7M 36.02% | 469.45M 344.89% | 1.607B 242.32% | 6.158B 283.20% | 11.148B 81.03% | 20.123B 80.51% | |
| Operating Margin | -35,513.98% | -146,091.67% | -58,097.11% | -2,302.78% | -212.60% | -69.48% | 54.58% | 88.93% | 147.67% | 156.93% | 164.00% | |
| EPS YoY % growth | -0.89 0.00% | -1.05 -17.98% | -1.13 -7.62% | -0.85 24.78% | -0.69 19.20% | -0.45 33.91% | 0.72 259.55% | 2.35 223.94% | 4.77 103.48% | 8.42 76.28% | 14.60 73.45% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 50.46% | -0.16 18.40% | -0.15 23.50% | -0.14 -19.00% | -0.13 23.53% |
| Revenue Q2Q % growth | 9.231M 6,541.01% | 20.42M 50,950.00% | 30.62M 2,824.55% | 38.27M 526.76% | 43.35M 369.61% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -94.362M -11.67% | -87.185M 8.42% | -78.77M 20.70% | -72.459M 9.71% | -61.19M 35.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.12 36.84% | -0.18 | 0.06 | 34.64% |
| Q2 2024 Q2Q % growth | -0.20 37.50% | -0.17 | -0.03 | -15.34% |
| Q1 2024 Q2Q % growth | -0.20 25.93% | -0.16 | -0.04 | -22.55% |
| Q4 2023 Q2Q % growth | -0.35 -29.63% | -0.18 | -0.17 | -90.63% |
| Q3 2023 Q2Q % growth | -0.19 32.14% | -0.26 | 0.07 | 26.95% |
| Q2 2023 Q2Q % growth | -0.32 -33.33% | -0.24 | -0.08 | -33.50% |
| Q1 2023 Q2Q % growth | -0.27 -3.85% | -0.28 | 0.01 | 1.96% |
| Q4 2022 Q2Q % growth | -0.27 -17.39% | -0.22 | -0.05 | -20.32% |
| Q3 2022 Q2Q % growth | -0.28 -27.27% | -0.23 | -0.05 | -19.35% |
| Q2 2022 Q2Q % growth | -0.24 -4.35% | -0.24 | 0.00 | 1.96% |
| Q1 2022 Q2Q % growth | -0.26 -23.81% | -0.22 | -0.04 | -15.86% |
| Q4 2021 Q2Q % growth | -0.23 23.33% | -0.21 | -0.02 | -7.38% |
| Q3 2021 Q2Q % growth | -0.22 -10.00% | -0.20 | -0.02 | -7.84% |
| Q2 2021 Q2Q % growth | -0.23 -15.00% | -0.12 | -0.11 | -87.91% |
| Q1 2021 Q2Q % growth | -0.21 -10.53% | -0.42 | 0.21 | 49.78% |
| Q4 2020 Q2Q % growth | -0.30 -87.50% | -0.18 | -0.12 | -63.40% |
| Q3 2020 Q2Q % growth | -0.20 -25.00% | -0.18 | -0.02 | -8.93% |
| Q2 2020 Q2Q % growth | -0.20 -17.65% | -0.19 | -0.01 | -3.20% |
| Q1 2020 Q2Q % growth | -0.19 13.64% | -0.17 | -0.02 | -9.57% |
| Q4 2019 Q2Q % growth | -0.16 27.27% | -0.20 | 0.04 | 21.57% |
| Q3 2019 Q2Q % growth | -0.16 46.67% | -0.19 | 0.03 | 13.81% |
| Q2 2019 Q2Q % growth | -0.17 51.43% | -0.25 | 0.08 | 30.70% |
| Q1 2019 Q2Q % growth | -0.22 37.14% | -0.24 | 0.02 | 8.22% |
| Q4 2018 Q2Q % growth | -0.22 | -0.32 | 0.10 | 31.53% |
| Q3 2018 Q2Q % growth | -0.30 | -0.38 | 0.08 | 21.08% |
| Q2 2018 Q2Q % growth | -0.35 | -0.39 | 0.04 | 9.22% |
| Q1 2018 Q2Q % growth | -0.35 | -0.35 | 0.00 | -0.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 6.106M 7,346.34% | 2.985M | 3.121M | 104.56% |
| Q2 2024 Q2Q % growth | 1.047M 2,453.66% | 2.57M | -1.523M | -59.26% |
| Q1 2024 Q2Q % growth | 40K -88.89% | 25.5K | 14.5K | 56.86% |
| Q4 2023 Q2Q % growth | 139K 98.57% | 25.5K | 113.5K | 445.10% |
| Q3 2023 Q2Q % growth | 82K -31.67% | 25.5K | 56.5K | 221.57% |
| Q2 2023 Q2Q % growth | 41K 2.50% | 25.5K | 15.5K | 60.78% |
| Q1 2023 Q2Q % growth | 360K 3,500.00% | 25.5K | 334.5K | 1,311.76% |
| Q4 2022 Q2Q % growth | 70K -82.05% | 25.5K | 44.5K | 174.51% |
| Q3 2022 Q2Q % growth | 120K 71.43% | 25.5K | 94.5K | 370.59% |
| Q2 2022 Q2Q % growth | 40K -88.24% | 25.5K | 14.5K | 56.86% |
| Q1 2022 Q2Q % growth | 10K -92.86% | 25.5K | -15.5K | -60.78% |
| Q4 2021 Q2Q % growth | 390K 360.00% | 25.5K | 364.5K | 1,429.41% |
| Q3 2021 Q2Q % growth | 70K -53.33% | 25.5K | 44.5K | 174.51% |
| Q2 2021 Q2Q % growth | 340K -22.73% | 25.5K | 314.5K | 1,233.33% |
| Q1 2021 Q2Q % growth | 140K -17.65% | 25.5K | 114.5K | 449.02% |
| Q4 2020 Q2Q % growth | -150K -106.91% | 15.3K | -165.3K | -1,080.39% |
| Q3 2020 Q2Q % growth | 150K 1,400.00% | 7.65K | 142.35K | 1,860.78% |
| Q2 2020 Q2Q % growth | 440K 2,100.00% | 7.65K | 432.35K | 5,651.63% |
| Q1 2020 Q2Q % growth | 170K 1,600.00% | 170K | % | |
| Q4 2019 Q2Q % growth | 2.17M 21,600.00% | % | ||
| Q3 2019 Q2Q % growth | 10K -66.67% | 10K | % | |
| Q1 2019 Q2Q % growth | 10K | 3.57K | 6.43K | 180.11% |
| Q4 2018 Q2Q % growth | 10K | 2.04K | 7.96K | 390.20% |
| Q3 2018 Q2Q % growth | 30K | 4.08K | 25.92K | 635.29% |
| Q2 2018 Q2Q % growth | 5.1K | -5.1K | -100.00% | |
| Q1 2018 Q2Q % growth | 10K | 4.08K | 5.92K | 145.10% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -13.33% | -1.63% | 3.1% |
| Revenue | 0% | -60.2% | 57.26% | 9.1% |